Commentary on varicella vaccination of children in the United States: Assessment after the first decade 1995-2005

Journal of Clinical Virology

Volumn 33, Issue 2, 2005, Pages 96-98

  Breuer, Judith ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; MEASLES MUMPS RUBELLA VACCINE;

CHICKENPOX; COST CONTROL; DRUG APPROVAL; EPIDEMIC; HEALTH CARE POLICY; HEALTH ECONOMICS; HEALTH PROGRAM; HERPES ZOSTER; HOSPITALIZATION; HUMAN; IMMUNITY; MORTALITY; NOTE; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VACCINATION; VIRUS REPLICATION; VIRUS TRANSMISSION; WILD TYPE;

EID: 19444362217     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2005.03.003     Document Type: Note

References (25)

1. J. Breuer Live attenuated vaccine for the prevention of varicella-zoster virus infection: does it work, is it safe and do we really need it in the UK? J Med Microbiol 52 January (Pt 1) 2003 1 3
2. J. Breuer Varicella vaccination for healthcare workers BMJ 330 February (7489) 2005 433 434
3. M. Brisson, and W.J. Edmunds The cost-effectiveness of varicella vaccination in Canada Vaccine 20 January (7-8) 2002 1113 1125
4. M. Brisson, and W.J. Edmunds Varicella vaccination in England and Wales: cost-utility analysis Arch Dis Child 88 October (10) 2003 862 869
5. M. Brisson, W.J. Edmunds, N.J. Gay, B. Law, and G. De Serres Analysis of varicella vaccine breakthrough rates: implications for the effectiveness of immunisation programmes Vaccine 18 June (25) 2000 2775 2778
6. M. Brisson, N.J. Gay, W.J. Edmunds, and N.J. Andrews Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox Vaccine 20 June (19-20) 2002 2500 2507
7. M. Brisson, W.J. Edmunds, and N.J. Gay Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV J Med Virol 70 Suppl. 1 2003 31 37
8. W.J. Edmunds, M. Brisson, and J.D. Rose The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales Vaccine 19 April (23-24) 2001 3076 3090
9. N.M. Ferguson, R.M. Anderson, and G.P. Garnett Mass vaccination to control chickenpox: the influence of zoster Proc Natl Acad Sci USA 93 July (14) 1996 7231 7235
10. K. Galil, B. Lee, T. Strine, C. Carraher, A.L. Baughman, and M. Eaton Outbreak of varicella at a day-care center despite vaccination N Engl J Med 347 2002 1909 1915
11. G.P. Garnett, and B.T. Grenfell The epidemiology of varicella-zoster virus infections: the influence of varicella on the prevalence of herpes zoster Epidemiol Infect 108 June (3) 1992 513 528
12. A.A. Gershon Varicella vaccine - are two doses better than one? N Engl J Med 347 December (24) 2002 1962 1963
13. Y. Gomi, H. Sunamachi, Y. Mori, K. Nagaike, M. Takahashi, and K. Yamanishi Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus J Virol 76 November (22) 2002 11447 11459
14. R. Horton The lessons of MMR Lancet 363 March (9411) 2004 747 749
15. P. LaRussa, S. Steinberg, and A.A. Gershon Varicella vaccine for immunocompromised children: results of collaborative studies in the United States and Canada J Infect Dis 174 November (Suppl. 3) 1996 S320 S323
16. B.R. Lee, S.L. Feaver, C.A. Miller, C.W. Hedberg, and K.R. Ehresmann An elementary school outbreak of varicella attributed to vaccine failure: policy implications J Infect Dis 190 2004 477 483
17. H.Q. Nguyen, A.O. Jumaan, and J.F. Seward Decline in mortality due to varicella after implementation of varicella vaccination in the United States N Engl J Med 352 February (5) 2005 450 458
18. T. Nolan, P. McIntyre, D. Roberton, and D. Descamps Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine Vaccine 21 December (3-4) 2002 281 289
19. M.N. Oxman Immunization to reduce the frequency and severity of herpes zoster and its complications Neurology 45 December (12 Suppl. 8) 1995 S41 S46
20. M.L. Quinlivan, A.A. Gershon, S.P. Steinberg, and J. Breuer Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from single clones of virus J Infect Dis 190 August (4) 2004 793 796
21. M.L. Quinlivan, A.A. Gershon, S.P. Steinberg, and J. Breuer An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild type strains of varicella-zoster virus J Med Virol 75 January (1) 2005 174 180
22. J.F. Seward, B.M. Watson, C.L. Peterson, L. Mascola, J.W. Pelosi, and J.X. Zhang Varicella disease after introduction of varicella vaccine in the United States, 1995-2000 JAMA 287 February (5) 2002 606 611
23. S.L. Thomas, J.G. Wheeler, and A.J. Hall Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study Lancet 360 August (9334) 2002 678 682
24. C.J. White, D. Stinson, B. Staehle, I. Cho, H. Matthews, and A. Ngai Kuter Measles, mumps, rubella, and varicella combination vaccine: safety and immunogenicity alone and in combination with other vaccines given to children. Measles, Mumps, Rubella, Varicella Vaccine Study Group Clin Infect Dis 24 May (5) 1997 925 931
25. L. Zerboni, S. Hinchliffe, M.H. Sommer, H. Ito, J. Besser, and S. Stamatis Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model Virology 332 February (1) 2005 337 346